Skip to main content
Clinical Trials/NL-OMON48436
NL-OMON48436
Completed
Not Applicable

Quantitative MRI of extra-ocular muscles in myasthenia gravis - Quantitative MRI of extra-ocular muscles in myasthenia gravis

eids Universitair Medisch Centrum0 sites89 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eids Universitair Medisch Centrum
Enrollment
89
Status
Completed
Last Updated
last year

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
October 4, 2022
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Recently diagnosed MG patients
  • \- Definitive diagnosis of MG defined as the presence of serum autoantibodies
  • (anti\-acetylcholine receptor \[AChR], anti\-muscle specific tyrosine kinase
  • \- Start of symptoms was less than a year ago
  • \- No corticosteroid treatment received in the past year
  • \- No TSH\-receptor auto\-antibodies, no laboratory signs of thyroid dysfunction
  • (T4, TSH), Chronic MG patients
  • \- Definitive diagnosis of MG, defined as described above
  • \- Persisting symptoms of diplopia
  • \- Start of symptoms was more than a year ago

Exclusion Criteria

  • \- Subjects who are not legally capable
  • \- Subjects under the age of 18
  • \- Contraindications to MRI scanning, including:
  • o Claustrophobia
  • o Pregnancy
  • o Pacemakers and defibrillators
  • o Nerve stimulators
  • o Intracranial clips
  • o Metallic fragments
  • o Cochlear implants

Outcomes

Primary Outcomes

Not specified

Similar Trials